NASDAQ : CMND
Clearmind Medicine Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 5.85 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year November - October; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 6.57M | 3.61M | 4.36M | 4.76M | 3.17M | 2.44M |
| Research & Development | 2.30M | 2.06M | 1.38M | 1.54M | 3.08M | 521.43K |
| Operating Expenses | 8.87M | 5.67M | 5.74M | 6.30M | 6.25M | 2.97M |
| Operating Income | -8.87M | -5.67M | -5.74M | -6.30M | -6.25M | -2.97M |
| Interest Expense | -7.41K | -19.54K | -36.16K | -10.89K | -14.42K | |
| Interest & Investment Income | 238.29K | 132.91K | 271.22K | 86.62K | ||
| Currency Exchange Gain (Loss) | 1.09K | 3.38K | -6.03K | -78.14K | -404.00 | -27.04K |
| Other Non Operating Income (Expenses) | 305.57K | 1.13M | 707.80K | -2.19M | -290.57K | |
| EBT Excluding Unusual Items | -8.33M | -4.42M | -4.81M | -8.50M | -6.56M | -3.00M |
| Gain (Loss) on Sale of Investments | 1.94M | 844.50K | -68.62K | -107.64K | -308.19K | |
| Other Unusual Items | -1.10M | -209.20K | ||||
| Pretax Income | -7.48M | -3.79M | -4.88M | -8.60M | -6.87M | -3.00M |
| Income Tax Expense | 12.70K | 70.44K | 377.97K | 17.37K | 29.86K | |
| Net Income | -7.50M | -3.86M | -5.25M | -8.62M | -6.89M | -3.00M |
| Net Income to Common | -7.50M | -3.86M | -5.25M | -8.62M | -6.89M | -3.00M |
| Free Cash Flow | -7.07M | -4.73M | -4.86M | -6.30M | -3.73M | -2.31M |
| EBITDA | -8.86M | -5.66M | -5.73M | -6.28M | -6.23M | -2.96M |
| D&A For EBITDA | 10.95K | 10.95K | 12.05K | 22.13K | 22.40K | 10.14K |
| EBIT | -8.87M | -5.67M | -5.74M | -6.30M | -6.25M | -2.97M |
Balance sheet
Fiscal year November - October; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.04M | 3.92M | 6.57M | 5.43M | 128.78K | 3.71M |
| Short-Term Investments | 3.89M | 1.66M | 289.39K | 86.11K | 193.75K | |
| Cash & Short-Term Investments | 15.93M | 5.59M | 6.86M | 5.51M | 322.53K | 3.71M |
| Other Receivables | 594.03K | 322.31K | 180.88K | 240.32K | 97.92K | 129.75K |
| Receivables | 594.03K | 322.31K | 180.88K | 240.32K | 97.92K | 129.75K |
| Prepaid Expenses | 103.36K | 39.94K | 44.16K | 40.40K | 14.24K | 129.10K |
| Total Current Assets | 16.63M | 5.95M | 7.09M | 5.79M | 434.69K | 3.97M |
| Property, Plant & Equipment | 175.22K | 17.40K | 51.66K | 1.73K | 48.63K | 16.60K |
| Other Intangible Assets | 89.18K | 97.37K | 108.33K | 119.31K | 130.26K | 159.73K |
| Long-Term Deferred Charges | 198.17K | |||||
| Other Long-Term Assets | 20.55K | 20.56K | 7.19K | 37.67K | 14.65K | 16.13K |
| Total Assets | 16.91M | 6.08M | 7.26M | 5.95M | 826.41K | 4.16M |
| Accounts Payable | 718.78K | 682.16K | 526.06K | 617.00K | 1.40M | 281.40K |
| Accrued Expenses | 69.69K | 60.23K | 48.96K | 42.43K | 206.49K | 6.66K |
| Current Portion of Long-Term Debt | 1.62M | 1.76M | ||||
| Current Portion of Leases | 74.53K | 18.80K | 36.73K | 38.39K | ||
| Other Current Liabilities | 1.37M | 2.37M | 3.52M | 4.31M | 290.57K | |
| Total Current Liabilities | 3.86M | 4.89M | 4.13M | 4.97M | 1.93M | 288.06K |
| Long-Term Leases | 101.92K | 16.42K | ||||
| Total Liabilities | 3.96M | 4.89M | 4.15M | 4.97M | 1.93M | 288.06K |
| Common Stock | 45.03M | 26.40M | 24.17M | 17.13M | 6.71M | 6.38M |
| Retained Earnings | -34.69M | -27.88M | -24.02M | -18.77M | -10.15M | -3.58M |
| Comprehensive Income & Other | 2.61M | 2.67M | 2.96M | 2.62M | 2.33M | 1.08M |
| Shareholders' Equity | 12.95M | 1.19M | 3.11M | 983.47K | -1.11M | 3.87M |
| Total Liabilities & Equity | 16.91M | 6.08M | 7.26M | 5.95M | 826.41K | 4.16M |
| Total Debt | 1.80M | 1.78M | 53.14K | 38.39K | ||
| Net Cash (Debt) | 14.13M | 3.81M | 6.81M | 5.51M | 284.14K | 3.71M |
| Working Capital | 12.77M | 1.06M | 2.96M | 824.76K | -1.50M | 3.68M |
| Tangible Book Value | 12.86M | 1.10M | 3.00M | 864.16K | -1.24M | 3.71M |
| Machinery | 18.67K |
Cash flow statement
Fiscal year November - October; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -7.50M | -3.86M | -5.25M | -8.62M | -6.89M | -3.00M |
| Depreciation & Amortization | 54.28K | 49.37K | 51.07K | 57.51K | 83.07K | 10.14K |
| Loss (Gain) From Sale of Investments | -1.94M | -844.50K | 68.62K | 107.64K | 308.19K | |
| Stock-Based Compensation | 1.79M | 805.89K | 998.92K | 834.81K | 1.21M | 682.47K |
| Other Operating Activities | 863.83K | -848.70K | -592.49K | 2.29M | 334.86K | |
| Change in Accounts Receivable | -108.48K | 17.25K | 64.95K | -154.62K | 19.94K | -127.23K |
| Change in Accounts Payable | 2.33K | 82.79K | -198.59K | -620.42K | 913.30K | 277.13K |
| Change in Other Net Operating Assets | -235.85K | -139.61K | 3.53K | -193.99K | 303.47K | -128.94K |
| Operating Cash Flow | -7.07M | -4.73M | -4.86M | -6.30M | -3.72M | -2.29M |
| Capital Expenditures | -5.56K | -26.74K | ||||
| Sale (Purchase) of Intangibles | -159.73K | |||||
| Investment in Securities | -1.50M | -528.52K | -271.90K | |||
| Other Investing Activities | -13.50K | 33.80K | -26.23K | -16.13K | ||
| Investing Cash Flow | -1.95M | -542.02K | -238.10K | -26.23K | -5.56K | -202.60K |
| Long-Term Debt Issued | 2.25M | |||||
| Long-Term Debt Repaid | -42.54K | -42.59K | -40.92K | -70.87K | ||
| Lease Payments | -47.99K | -42.54K | -42.59K | -40.92K | -70.87K | |
| Net Debt Issued (Repaid) | 10.08M | 2.21M | -42.59K | -40.92K | -70.87K | |
| Issuance of Common Stock | 7.49M | 415.09K | 6.30M | 11.71M | 582.56K | 5.93M |
| Financing Cash Flow | 17.57M | 2.62M | 6.25M | 11.66M | 511.69K | 5.93M |
| Foreign Exchange Rate Adjustments | -7.67K | 3.22K | -11.55K | -37.73K | -22.65K | |
| Net Cash Flow | 8.54M | -2.65M | 1.15M | 5.30M | -3.24M | 3.44M |
| Free Cash Flow | -7.07M | -4.73M | -4.86M | -6.30M | -3.73M | -2.31M |
| Levered Free Cash Flow | -4.78M | -3.82M | -3.13M | -146.90K | -875.81K | -1.33M |
| Unlevered Free Cash Flow | -4.78M | -3.81M | -3.11M | -140.09K | -866.80K | -1.33M |
| Free Cash Flow After Leases | -7.12M | -4.78M | -4.90M | -6.34M | -3.80M | -2.31M |
| Cash Interest Paid | 3.86K | 3.86K | 5.39K | 2.91K | 14.43K | |
| Cash Income Tax Paid | 83.80K | 229.91K | 306.59K | 12.68K | ||
| Change in Working Capital | -342.01K | -39.57K | -130.11K | -969.03K | 1.24M | 20.96K |
Ratios
Fiscal year November - October; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.62M | 434.79K | 563.56K | 177.88K | 985.92K | 2.22M |
| Enterprise Value | -11.51M | -3.03M | -7.06M | -3.79M | 385.95K | -3.07M |
| Last Close Price | 6.22 | 254.56 | 444.80 | 1,170.24 | 75,840.05 | 170,756.29 |
| PB Ratio | 0.13 | 0.36 | 0.18 | 0.18 | -0.89 | 0.57 |
| P/TBV Ratio | 0.20 | 0.40 | 0.19 | 0.21 | 0.60 | |
| Debt / Equity Ratio | 0.14 | 1.49 | 0.02 | -0.04 | ||
| Net Debt / Equity Ratio | -1.09 | -3.19 | -2.19 | -5.61 | 0.26 | -0.96 |
| Net Debt / EBITDA Ratio | 1.60 | 0.67 | 1.19 | 0.88 | 0.05 | 1.25 |
| Net Debt / FCF Ratio | 2.00 | 0.80 | 1.40 | 0.88 | 0.08 | 1.60 |
| Quick Ratio | 4.28 | 1.21 | 1.71 | 1.16 | 0.22 | 13.33 |
| Current Ratio | 4.31 | 1.22 | 1.72 | 1.17 | 0.23 | 13.78 |
| Return on Equity (ROE) | -106.98% | -179.39% | -256.89% | -570.96% | -145.26% | |
| Return on Assets (ROA) | -53.08% | -53.11% | -54.37% | -116.22% | -169.53% | -83.90% |
| Return on Capital Employed (ROCE) | -67.90% | -475.20% | -183.90% | -640.90% | 565.20% | -76.80% |
| Earnings Yield | -1,904.04% | -887.10% | -932.40% | -4,846.52% | -699.33% | -135.15% |
| FCF Yield | -270.09% | -1,088.92% | -862.13% | -3,542.60% | -378.33% | -104.21% |